- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
AstraZeneca (AZNL)
12,776.00p
- Change Today: -34.00p
- 52 Week High: 12,838.00
- 52 Week Low: 9,642.00
- Currency: UK Pounds
- Shares Issued: 1,264.16m
- Volume: 134,085
- Market Cap: £161,509m
Latest ShareCast News
Germany's Cheplapharm pays AstraZeneca $200m for Atacand rights
By Frank Prenesti
Date: Monday 01 Oct 2018
(Sharecast News) - AstraZeneca said it had agreed a $200m deal with Germany's Cheplapharm Arzneimittel for the European commercial rights to Atacand and Atacand Plus heart and hypertension treatments.
AstraZeneca ShareCast News
| Sunday share tips: AstraZeneca, Genus, 'Dogs of ... | 30-Jul-2017 | ShareCast |
| AstraZeneca co-develops treatment for Alzheimer'... | 09-Dec-2016 | ShareCast |
AstraZeneca Regulatory News
No recent information was found.
AstraZeneca Newspaper Links
AstraZeneca Tips & Analysis
| Questor :AstraZeneca | 29-Apr-2014 | Telegraph |
| Questor : AstraZeneca | 24-Jan-2014 | Telegraph |
| Questor:AstraZeneca | 22-Dec-2011 | Telegraph |
| Investment Column:AstraZeneca | 28-Oct-2011 | The Independent |
| Investment Column: AstraZeneca | 23-Jun-2011 | The Independent |
AstraZeneca News Wires
AstraZeneca Market Data
| Currency | UK Pounds |
| Share Price | 12,776.00p |
| Change Today | -34.00p |
| % Change | -0.27 % |
| 52 Week High | 12,838.00 |
| 52 Week Low | 9,642.00 |
| Volume | 134,085 |
| Shares Issued | 1,264.16m |
| Market Cap | £161,509m |
Trades for 09-Oct-2025
| Time | Volume / Share Price |
| 11:52 | 52 @ 12,776.00p |
| 11:52 | 15 @ 12,776.00p |
| 11:52 | 26 @ 12,776.00p |
| 11:52 | 10 @ 12,778.00p |
| 11:51 | 42 @ 12,780.00p |
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN